US 7919260
Screening methods using GPR52
granted A61PA61P25/16A61P25/18
Quick answer
US patent 7919260 (Screening methods using GPR52) held by Takeda Pharmaceutical Company Limited expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61P, A61P25/16, A61P25/18, A61P25/28, A61P43/00